Will the FDA approve MAIA Biotechnology's THIO-101 for the treatment of advanced Non-Small Cell Lung Cancer by Jan 2030?
3
90Ṁ1112030
84%
chance
1D
1W
1M
ALL
1: The market resolves as "Yes" if the U.S. Food and Drug Administration (FDA) grants full or conditional approval for THIO-101 as a treatment for advanced Non-Small Cell Lung Cancer by the specified date.
2: The market resolves as "No" if the FDA explicitly rejects the application for THIO-101 for the mentioned indication by the specified date.
3: If neither approval nor rejection is announced by the FDA by the specified date, the market will resolve as "No."
Context: https://www.businesswire.com/news/home/20231024406334/en/
This question is managed and resolved by Manifold.
Get
1,000 to start trading!
1,000Related questions
Related questions
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
55% chance
Will FDA approve any mRNA vaccine against small-cell lung carcinoma before 2028?
21% chance
Will there be an FDA approved cure for ALS (Lou Gehrig Disease) by EOY 2032?
31% chance
💊Will INS018_055 be FDA-approved by 2030?
48% chance
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
43% chance
Will FDA approve any mRNA vaccine against mesothelioma before 2028?
30% chance
Will a novel therapeutic/device which confers a survival benefit for glioblastoma be FDA approved by EOY 2028?
51% chance
Will an AI-designed drug get FDA approval by the end of 2025?
19% chance
When will the "100% effective against solid tumors" cancer pill AOH1996 be approved by the FDA?
Will a drug that didn't go through human clinical trials be approved by 2034?
29% chance